nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP2D6—Alzheimer's disease	0.35	1	CbGaD
Dexmedetomidine—CYP2D6—Rivastigmine—Alzheimer's disease	0.11	0.432	CbGbCtD
Dexmedetomidine—CYP2D6—Donepezil—Alzheimer's disease	0.0882	0.345	CbGbCtD
Dexmedetomidine—CYP2D6—Galantamine—Alzheimer's disease	0.0568	0.223	CbGbCtD
Dexmedetomidine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00935	0.269	CbGeAlD
Dexmedetomidine—ADRA1D—forebrain—Alzheimer's disease	0.00187	0.0539	CbGeAlD
Dexmedetomidine—ADRA1D—telencephalon—Alzheimer's disease	0.00172	0.0495	CbGeAlD
Dexmedetomidine—Pleural effusion—Rivastigmine—Alzheimer's disease	0.00154	0.00561	CcSEcCtD
Dexmedetomidine—Rigors—Memantine—Alzheimer's disease	0.00148	0.00538	CcSEcCtD
Dexmedetomidine—Myocardial ischaemia—Rivastigmine—Alzheimer's disease	0.00147	0.00535	CcSEcCtD
Dexmedetomidine—Gamma-glutamyltransferase increased—Memantine—Alzheimer's disease	0.00146	0.00534	CcSEcCtD
Dexmedetomidine—Hyperbilirubinaemia—Donepezil—Alzheimer's disease	0.00146	0.00532	CcSEcCtD
Dexmedetomidine—Rigors—Rivastigmine—Alzheimer's disease	0.00144	0.00526	CcSEcCtD
Dexmedetomidine—Extrasystoles—Memantine—Alzheimer's disease	0.00143	0.00522	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Galantamine—Alzheimer's disease	0.00143	0.00521	CcSEcCtD
Dexmedetomidine—Apnoea—Memantine—Alzheimer's disease	0.00142	0.00518	CcSEcCtD
Dexmedetomidine—Leukocytosis—Donepezil—Alzheimer's disease	0.00141	0.00515	CcSEcCtD
Dexmedetomidine—Speech disorder—Memantine—Alzheimer's disease	0.0014	0.00511	CcSEcCtD
Dexmedetomidine—Delirium—Memantine—Alzheimer's disease	0.0014	0.00511	CcSEcCtD
Dexmedetomidine—Extrasystoles—Rivastigmine—Alzheimer's disease	0.0014	0.00511	CcSEcCtD
Dexmedetomidine—Apnoea—Rivastigmine—Alzheimer's disease	0.00139	0.00507	CcSEcCtD
Dexmedetomidine—Cardiovascular disorder—Memantine—Alzheimer's disease	0.00137	0.005	CcSEcCtD
Dexmedetomidine—Speech disorder—Rivastigmine—Alzheimer's disease	0.00137	0.005	CcSEcCtD
Dexmedetomidine—Delirium—Rivastigmine—Alzheimer's disease	0.00137	0.005	CcSEcCtD
Dexmedetomidine—Atrioventricular block—Donepezil—Alzheimer's disease	0.00137	0.00499	CcSEcCtD
Dexmedetomidine—Cardiovascular disorder—Rivastigmine—Alzheimer's disease	0.00134	0.00489	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Donepezil—Alzheimer's disease	0.00133	0.00484	CcSEcCtD
Dexmedetomidine—Hyperbilirubinaemia—Memantine—Alzheimer's disease	0.00132	0.00483	CcSEcCtD
Dexmedetomidine—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00131	0.00478	CcSEcCtD
Dexmedetomidine—Wheezing—Donepezil—Alzheimer's disease	0.00129	0.0047	CcSEcCtD
Dexmedetomidine—Leukocytosis—Memantine—Alzheimer's disease	0.00128	0.00468	CcSEcCtD
Dexmedetomidine—Oliguria—Rivastigmine—Alzheimer's disease	0.00128	0.00466	CcSEcCtD
Dexmedetomidine—Leukocytosis—Rivastigmine—Alzheimer's disease	0.00125	0.00457	CcSEcCtD
Dexmedetomidine—Blood urea increased—Donepezil—Alzheimer's disease	0.00125	0.00457	CcSEcCtD
Dexmedetomidine—Atrioventricular block—Memantine—Alzheimer's disease	0.00124	0.00453	CcSEcCtD
Dexmedetomidine—Respiratory failure—Memantine—Alzheimer's disease	0.00123	0.00447	CcSEcCtD
Dexmedetomidine—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00121	0.00443	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Memantine—Alzheimer's disease	0.0012	0.00439	CcSEcCtD
Dexmedetomidine—Respiratory failure—Rivastigmine—Alzheimer's disease	0.0012	0.00438	CcSEcCtD
Dexmedetomidine—Hyperkalaemia—Memantine—Alzheimer's disease	0.00118	0.00432	CcSEcCtD
Dexmedetomidine—Phosphatase alkaline increased—Rivastigmine—Alzheimer's disease	0.00118	0.0043	CcSEcCtD
Dexmedetomidine—SLC6A2—forebrain—Alzheimer's disease	0.00116	0.0333	CbGeAlD
Dexmedetomidine—Abnormal vision—Donepezil—Alzheimer's disease	0.00116	0.00422	CcSEcCtD
Dexmedetomidine—Sepsis—Donepezil—Alzheimer's disease	0.00115	0.0042	CcSEcCtD
Dexmedetomidine—Blood urea increased—Memantine—Alzheimer's disease	0.00114	0.00415	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Galantamine—Alzheimer's disease	0.00113	0.00413	CcSEcCtD
Dexmedetomidine—Fluid retention—Rivastigmine—Alzheimer's disease	0.00112	0.00408	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Donepezil—Alzheimer's disease	0.00111	0.00404	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Memantine—Alzheimer's disease	0.00107	0.00391	CcSEcCtD
Dexmedetomidine—SLC6A2—telencephalon—Alzheimer's disease	0.00106	0.0306	CbGeAlD
Dexmedetomidine—Abnormal vision—Memantine—Alzheimer's disease	0.00105	0.00383	CcSEcCtD
Dexmedetomidine—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00105	0.00383	CcSEcCtD
Dexmedetomidine—Sepsis—Memantine—Alzheimer's disease	0.00105	0.00381	CcSEcCtD
Dexmedetomidine—ADRA1B—nervous system—Alzheimer's disease	0.00104	0.0299	CbGeAlD
Dexmedetomidine—Abnormal vision—Rivastigmine—Alzheimer's disease	0.00103	0.00375	CcSEcCtD
Dexmedetomidine—Sepsis—Rivastigmine—Alzheimer's disease	0.00102	0.00373	CcSEcCtD
Dexmedetomidine—ADRA1D—nervous system—Alzheimer's disease	0.00102	0.0292	CbGeAlD
Dexmedetomidine—Atrial fibrillation—Donepezil—Alzheimer's disease	0.00102	0.00371	CcSEcCtD
Dexmedetomidine—Thirst—Donepezil—Alzheimer's disease	0.00101	0.00369	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Memantine—Alzheimer's disease	0.00101	0.00367	CcSEcCtD
Dexmedetomidine—ADRA1B—central nervous system—Alzheimer's disease	0.001	0.0288	CbGeAlD
Dexmedetomidine—Hepatic function abnormal—Memantine—Alzheimer's disease	0.001	0.00365	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Donepezil—Alzheimer's disease	0.000987	0.0036	CcSEcCtD
Dexmedetomidine—Blood alkaline phosphatase increased—Rivastigmine—Alzheimer's disease	0.000983	0.00359	CcSEcCtD
Dexmedetomidine—ADRA1D—central nervous system—Alzheimer's disease	0.000979	0.0282	CbGeAlD
Dexmedetomidine—Hyperglycaemia—Galantamine—Alzheimer's disease	0.000969	0.00353	CcSEcCtD
Dexmedetomidine—Pneumonia—Galantamine—Alzheimer's disease	0.000963	0.00351	CcSEcCtD
Dexmedetomidine—Renal failure acute—Memantine—Alzheimer's disease	0.000947	0.00345	CcSEcCtD
Dexmedetomidine—ADRA2C—telencephalon—Alzheimer's disease	0.000943	0.0271	CbGeAlD
Dexmedetomidine—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000939	0.00342	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Galantamine—Alzheimer's disease	0.000931	0.0034	CcSEcCtD
Dexmedetomidine—Renal failure acute—Rivastigmine—Alzheimer's disease	0.000926	0.00338	CcSEcCtD
Dexmedetomidine—Atrial fibrillation—Memantine—Alzheimer's disease	0.000923	0.00337	CcSEcCtD
Dexmedetomidine—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000903	0.00329	CcSEcCtD
Dexmedetomidine—Thirst—Rivastigmine—Alzheimer's disease	0.000899	0.00328	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Memantine—Alzheimer's disease	0.000896	0.00327	CcSEcCtD
Dexmedetomidine—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.000876	0.0032	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Donepezil—Alzheimer's disease	0.000876	0.0032	CcSEcCtD
Dexmedetomidine—Bradycardia—Galantamine—Alzheimer's disease	0.000875	0.00319	CcSEcCtD
Dexmedetomidine—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.000867	0.00316	CcSEcCtD
Dexmedetomidine—Haemoglobin—Galantamine—Alzheimer's disease	0.000864	0.00315	CcSEcCtD
Dexmedetomidine—Haemorrhage—Galantamine—Alzheimer's disease	0.00086	0.00314	CcSEcCtD
Dexmedetomidine—Hallucination—Galantamine—Alzheimer's disease	0.000855	0.00312	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000849	0.0031	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Galantamine—Alzheimer's disease	0.000847	0.00309	CcSEcCtD
Dexmedetomidine—Abdominal distension—Donepezil—Alzheimer's disease	0.000838	0.00306	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Memantine—Alzheimer's disease	0.000831	0.00303	CcSEcCtD
Dexmedetomidine—Visual impairment—Galantamine—Alzheimer's disease	0.000828	0.00302	CcSEcCtD
Dexmedetomidine—ADRA2A—forebrain—Alzheimer's disease	0.000818	0.0235	CbGeAlD
Dexmedetomidine—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000813	0.00297	CcSEcCtD
Dexmedetomidine—Sweating increased—Donepezil—Alzheimer's disease	0.000811	0.00296	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Galantamine—Alzheimer's disease	0.000798	0.00291	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Memantine—Alzheimer's disease	0.000796	0.0029	CcSEcCtD
Dexmedetomidine—ADRA1B—brain—Alzheimer's disease	0.000795	0.0229	CbGeAlD
Dexmedetomidine—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000787	0.00287	CcSEcCtD
Dexmedetomidine—Angiopathy—Galantamine—Alzheimer's disease	0.00078	0.00284	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000778	0.00284	CcSEcCtD
Dexmedetomidine—ADRA1D—brain—Alzheimer's disease	0.000777	0.0224	CbGeAlD
Dexmedetomidine—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000771	0.00281	CcSEcCtD
Dexmedetomidine—Arrhythmia—Galantamine—Alzheimer's disease	0.000768	0.0028	CcSEcCtD
Dexmedetomidine—Mental disorder—Galantamine—Alzheimer's disease	0.000753	0.00275	CcSEcCtD
Dexmedetomidine—ADRA2A—telencephalon—Alzheimer's disease	0.000752	0.0216	CbGeAlD
Dexmedetomidine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000751	0.00274	CcSEcCtD
Dexmedetomidine—Malnutrition—Galantamine—Alzheimer's disease	0.000748	0.00273	CcSEcCtD
Dexmedetomidine—Pneumonia—Donepezil—Alzheimer's disease	0.000746	0.00272	CcSEcCtD
Dexmedetomidine—Bronchospasm—Memantine—Alzheimer's disease	0.000743	0.00271	CcSEcCtD
Dexmedetomidine—Sweating increased—Memantine—Alzheimer's disease	0.000736	0.00269	CcSEcCtD
Dexmedetomidine—CYP2E1—telencephalon—Alzheimer's disease	0.000736	0.0212	CbGeAlD
Dexmedetomidine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000732	0.00267	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000727	0.00265	CcSEcCtD
Dexmedetomidine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000727	0.00265	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Donepezil—Alzheimer's disease	0.000721	0.00263	CcSEcCtD
Dexmedetomidine—Sweating increased—Rivastigmine—Alzheimer's disease	0.00072	0.00263	CcSEcCtD
Dexmedetomidine—Anaemia—Galantamine—Alzheimer's disease	0.000692	0.00252	CcSEcCtD
Dexmedetomidine—Agitation—Galantamine—Alzheimer's disease	0.000688	0.00251	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Memantine—Alzheimer's disease	0.000682	0.00249	CcSEcCtD
Dexmedetomidine—Bradycardia—Donepezil—Alzheimer's disease	0.000678	0.00247	CcSEcCtD
Dexmedetomidine—Pneumonia—Memantine—Alzheimer's disease	0.000678	0.00247	CcSEcCtD
Dexmedetomidine—Haemoglobin—Donepezil—Alzheimer's disease	0.00067	0.00244	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000667	0.00243	CcSEcCtD
Dexmedetomidine—Haemorrhage—Donepezil—Alzheimer's disease	0.000666	0.00243	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000664	0.00242	CcSEcCtD
Dexmedetomidine—Pneumonia—Rivastigmine—Alzheimer's disease	0.000663	0.00242	CcSEcCtD
Dexmedetomidine—Hallucination—Donepezil—Alzheimer's disease	0.000663	0.00242	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Memantine—Alzheimer's disease	0.00066	0.00241	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00066	0.00241	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000656	0.00239	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Memantine—Alzheimer's disease	0.000655	0.00239	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00065	0.00237	CcSEcCtD
Dexmedetomidine—Convulsion—Galantamine—Alzheimer's disease	0.000648	0.00237	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000646	0.00236	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000646	0.00236	CcSEcCtD
Dexmedetomidine—Hypertension—Galantamine—Alzheimer's disease	0.000646	0.00236	CcSEcCtD
Dexmedetomidine—Visual impairment—Donepezil—Alzheimer's disease	0.000642	0.00234	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000641	0.00234	CcSEcCtD
Dexmedetomidine—Anxiety—Galantamine—Alzheimer's disease	0.000635	0.00232	CcSEcCtD
Dexmedetomidine—CYP2D6—forebrain—Alzheimer's disease	0.000634	0.0182	CbGeAlD
Dexmedetomidine—SLC6A2—nervous system—Alzheimer's disease	0.000628	0.0181	CbGeAlD
Dexmedetomidine—Dry mouth—Galantamine—Alzheimer's disease	0.000623	0.00227	CcSEcCtD
Dexmedetomidine—Confusional state—Galantamine—Alzheimer's disease	0.000616	0.00225	CcSEcCtD
Dexmedetomidine—Bradycardia—Memantine—Alzheimer's disease	0.000616	0.00225	CcSEcCtD
Dexmedetomidine—Haemoglobin—Memantine—Alzheimer's disease	0.000608	0.00222	CcSEcCtD
Dexmedetomidine—SLC6A2—central nervous system—Alzheimer's disease	0.000605	0.0174	CbGeAlD
Dexmedetomidine—Haemorrhage—Memantine—Alzheimer's disease	0.000605	0.00221	CcSEcCtD
Dexmedetomidine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000602	0.0022	CcSEcCtD
Dexmedetomidine—Hallucination—Memantine—Alzheimer's disease	0.000602	0.0022	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000598	0.00218	CcSEcCtD
Dexmedetomidine—Chills—Donepezil—Alzheimer's disease	0.000598	0.00218	CcSEcCtD
Dexmedetomidine—Tachycardia—Galantamine—Alzheimer's disease	0.000596	0.00217	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Memantine—Alzheimer's disease	0.000596	0.00217	CcSEcCtD
Dexmedetomidine—Arrhythmia—Donepezil—Alzheimer's disease	0.000595	0.00217	CcSEcCtD
Dexmedetomidine—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000595	0.00217	CcSEcCtD
Dexmedetomidine—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000592	0.00216	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00059	0.00215	CcSEcCtD
Dexmedetomidine—Hallucination—Rivastigmine—Alzheimer's disease	0.000589	0.00215	CcSEcCtD
Dexmedetomidine—Mental disorder—Donepezil—Alzheimer's disease	0.000584	0.00213	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000583	0.00213	CcSEcCtD
Dexmedetomidine—Visual impairment—Memantine—Alzheimer's disease	0.000583	0.00213	CcSEcCtD
Dexmedetomidine—CYP2D6—telencephalon—Alzheimer's disease	0.000583	0.0168	CbGeAlD
Dexmedetomidine—Malnutrition—Donepezil—Alzheimer's disease	0.00058	0.00212	CcSEcCtD
Dexmedetomidine—Hypotension—Galantamine—Alzheimer's disease	0.000571	0.00208	CcSEcCtD
Dexmedetomidine—Visual impairment—Rivastigmine—Alzheimer's disease	0.00057	0.00208	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Memantine—Alzheimer's disease	0.000561	0.00205	CcSEcCtD
Dexmedetomidine—ADRA2C—nervous system—Alzheimer's disease	0.000557	0.016	CbGeAlD
Dexmedetomidine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000549	0.002	CcSEcCtD
Dexmedetomidine—Angiopathy—Memantine—Alzheimer's disease	0.000549	0.002	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000545	0.00199	CcSEcCtD
Dexmedetomidine—Somnolence—Galantamine—Alzheimer's disease	0.000543	0.00198	CcSEcCtD
Dexmedetomidine—Chills—Memantine—Alzheimer's disease	0.000543	0.00198	CcSEcCtD
Dexmedetomidine—Arrhythmia—Memantine—Alzheimer's disease	0.00054	0.00197	CcSEcCtD
Dexmedetomidine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000537	0.00196	CcSEcCtD
Dexmedetomidine—Anaemia—Donepezil—Alzheimer's disease	0.000536	0.00196	CcSEcCtD
Dexmedetomidine—ADRA2C—central nervous system—Alzheimer's disease	0.000536	0.0154	CbGeAlD
Dexmedetomidine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000533	0.00195	CcSEcCtD
Dexmedetomidine—Agitation—Donepezil—Alzheimer's disease	0.000533	0.00194	CcSEcCtD
Dexmedetomidine—Chills—Rivastigmine—Alzheimer's disease	0.000531	0.00194	CcSEcCtD
Dexmedetomidine—Mental disorder—Memantine—Alzheimer's disease	0.00053	0.00193	CcSEcCtD
Dexmedetomidine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000529	0.00193	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000527	0.00192	CcSEcCtD
Dexmedetomidine—Malnutrition—Memantine—Alzheimer's disease	0.000527	0.00192	CcSEcCtD
Dexmedetomidine—ADRA2C—cerebellum—Alzheimer's disease	0.000524	0.0151	CbGeAlD
Dexmedetomidine—Constipation—Galantamine—Alzheimer's disease	0.000522	0.00191	CcSEcCtD
Dexmedetomidine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000518	0.00189	CcSEcCtD
Dexmedetomidine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000515	0.00188	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000503	0.00184	CcSEcCtD
Dexmedetomidine—Convulsion—Donepezil—Alzheimer's disease	0.000502	0.00183	CcSEcCtD
Dexmedetomidine—Hypertension—Donepezil—Alzheimer's disease	0.000501	0.00183	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000499	0.00182	CcSEcCtD
Dexmedetomidine—Anxiety—Donepezil—Alzheimer's disease	0.000492	0.00179	CcSEcCtD
Dexmedetomidine—Anaemia—Memantine—Alzheimer's disease	0.000487	0.00178	CcSEcCtD
Dexmedetomidine—Agitation—Memantine—Alzheimer's disease	0.000484	0.00177	CcSEcCtD
Dexmedetomidine—Dry mouth—Donepezil—Alzheimer's disease	0.000483	0.00176	CcSEcCtD
Dexmedetomidine—Abdominal pain—Galantamine—Alzheimer's disease	0.000483	0.00176	CcSEcCtD
Dexmedetomidine—Body temperature increased—Galantamine—Alzheimer's disease	0.000483	0.00176	CcSEcCtD
Dexmedetomidine—SLC6A2—brain—Alzheimer's disease	0.00048	0.0138	CbGeAlD
Dexmedetomidine—Confusional state—Donepezil—Alzheimer's disease	0.000477	0.00174	CcSEcCtD
Dexmedetomidine—CYP1A1—nervous system—Alzheimer's disease	0.000476	0.0137	CbGeAlD
Dexmedetomidine—Anaemia—Rivastigmine—Alzheimer's disease	0.000476	0.00174	CcSEcCtD
Dexmedetomidine—Agitation—Rivastigmine—Alzheimer's disease	0.000473	0.00173	CcSEcCtD
Dexmedetomidine—Infection—Donepezil—Alzheimer's disease	0.00047	0.00172	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000463	0.00169	CcSEcCtD
Dexmedetomidine—CYP1A1—central nervous system—Alzheimer's disease	0.000459	0.0132	CbGeAlD
Dexmedetomidine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000458	0.00167	CcSEcCtD
Dexmedetomidine—Convulsion—Memantine—Alzheimer's disease	0.000456	0.00166	CcSEcCtD
Dexmedetomidine—Hypertension—Memantine—Alzheimer's disease	0.000455	0.00166	CcSEcCtD
Dexmedetomidine—Anxiety—Memantine—Alzheimer's disease	0.000447	0.00163	CcSEcCtD
Dexmedetomidine—Convulsion—Rivastigmine—Alzheimer's disease	0.000446	0.00163	CcSEcCtD
Dexmedetomidine—Hypertension—Rivastigmine—Alzheimer's disease	0.000445	0.00162	CcSEcCtD
Dexmedetomidine—ADRA2A—nervous system—Alzheimer's disease	0.000444	0.0128	CbGeAlD
Dexmedetomidine—Hypotension—Donepezil—Alzheimer's disease	0.000442	0.00161	CcSEcCtD
Dexmedetomidine—Dry mouth—Memantine—Alzheimer's disease	0.000438	0.0016	CcSEcCtD
Dexmedetomidine—Anxiety—Rivastigmine—Alzheimer's disease	0.000437	0.00159	CcSEcCtD
Dexmedetomidine—CYP2E1—nervous system—Alzheimer's disease	0.000434	0.0125	CbGeAlD
Dexmedetomidine—Confusional state—Memantine—Alzheimer's disease	0.000433	0.00158	CcSEcCtD
Dexmedetomidine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000429	0.00156	CcSEcCtD
Dexmedetomidine—ADRA2A—central nervous system—Alzheimer's disease	0.000428	0.0123	CbGeAlD
Dexmedetomidine—Infection—Memantine—Alzheimer's disease	0.000427	0.00156	CcSEcCtD
Dexmedetomidine—ADRA2C—brain—Alzheimer's disease	0.000425	0.0122	CbGeAlD
Dexmedetomidine—Confusional state—Rivastigmine—Alzheimer's disease	0.000424	0.00155	CcSEcCtD
Dexmedetomidine—Dyspnoea—Donepezil—Alzheimer's disease	0.000422	0.00154	CcSEcCtD
Dexmedetomidine—Somnolence—Donepezil—Alzheimer's disease	0.000421	0.00153	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000421	0.00153	CcSEcCtD
Dexmedetomidine—Tachycardia—Memantine—Alzheimer's disease	0.000419	0.00153	CcSEcCtD
Dexmedetomidine—CYP2E1—central nervous system—Alzheimer's disease	0.000418	0.012	CbGeAlD
Dexmedetomidine—ADRA2A—cerebellum—Alzheimer's disease	0.000418	0.012	CbGeAlD
Dexmedetomidine—Diarrhoea—Galantamine—Alzheimer's disease	0.000418	0.00152	CcSEcCtD
Dexmedetomidine—Infection—Rivastigmine—Alzheimer's disease	0.000418	0.00152	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000415	0.00152	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000412	0.0015	CcSEcCtD
Dexmedetomidine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00041	0.0015	CcSEcCtD
Dexmedetomidine—CYP2E1—cerebellum—Alzheimer's disease	0.000409	0.0118	CbGeAlD
Dexmedetomidine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000409	0.00149	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000406	0.00148	CcSEcCtD
Dexmedetomidine—Constipation—Donepezil—Alzheimer's disease	0.000405	0.00148	CcSEcCtD
Dexmedetomidine—Pain—Donepezil—Alzheimer's disease	0.000405	0.00148	CcSEcCtD
Dexmedetomidine—Dizziness—Galantamine—Alzheimer's disease	0.000404	0.00147	CcSEcCtD
Dexmedetomidine—Hypotension—Memantine—Alzheimer's disease	0.000402	0.00146	CcSEcCtD
Dexmedetomidine—Hypotension—Rivastigmine—Alzheimer's disease	0.000393	0.00143	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Donepezil—Alzheimer's disease	0.00039	0.00142	CcSEcCtD
Dexmedetomidine—Vomiting—Galantamine—Alzheimer's disease	0.000388	0.00142	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000387	0.00141	CcSEcCtD
Dexmedetomidine—Rash—Galantamine—Alzheimer's disease	0.000385	0.0014	CcSEcCtD
Dexmedetomidine—Dermatitis—Galantamine—Alzheimer's disease	0.000385	0.0014	CcSEcCtD
Dexmedetomidine—Dyspnoea—Memantine—Alzheimer's disease	0.000383	0.0014	CcSEcCtD
Dexmedetomidine—Headache—Galantamine—Alzheimer's disease	0.000383	0.0014	CcSEcCtD
Dexmedetomidine—Somnolence—Memantine—Alzheimer's disease	0.000382	0.00139	CcSEcCtD
Dexmedetomidine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000375	0.00137	CcSEcCtD
Dexmedetomidine—Body temperature increased—Donepezil—Alzheimer's disease	0.000374	0.00136	CcSEcCtD
Dexmedetomidine—Abdominal pain—Donepezil—Alzheimer's disease	0.000374	0.00136	CcSEcCtD
Dexmedetomidine—Somnolence—Rivastigmine—Alzheimer's disease	0.000374	0.00136	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000371	0.00135	CcSEcCtD
Dexmedetomidine—Pain—Memantine—Alzheimer's disease	0.000367	0.00134	CcSEcCtD
Dexmedetomidine—Constipation—Memantine—Alzheimer's disease	0.000367	0.00134	CcSEcCtD
Dexmedetomidine—CYP1A1—brain—Alzheimer's disease	0.000364	0.0105	CbGeAlD
Dexmedetomidine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000363	0.00132	CcSEcCtD
Dexmedetomidine—Nausea—Galantamine—Alzheimer's disease	0.000363	0.00132	CcSEcCtD
Dexmedetomidine—Constipation—Rivastigmine—Alzheimer's disease	0.000359	0.00131	CcSEcCtD
Dexmedetomidine—Pain—Rivastigmine—Alzheimer's disease	0.000359	0.00131	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Memantine—Alzheimer's disease	0.000354	0.00129	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000351	0.00128	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000346	0.00126	CcSEcCtD
Dexmedetomidine—CYP2D6—nervous system—Alzheimer's disease	0.000344	0.00989	CbGeAlD
Dexmedetomidine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000344	0.00125	CcSEcCtD
Dexmedetomidine—Abdominal pain—Memantine—Alzheimer's disease	0.00034	0.00124	CcSEcCtD
Dexmedetomidine—Body temperature increased—Memantine—Alzheimer's disease	0.00034	0.00124	CcSEcCtD
Dexmedetomidine—ADRA2A—brain—Alzheimer's disease	0.000339	0.00976	CbGeAlD
Dexmedetomidine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000332	0.00121	CcSEcCtD
Dexmedetomidine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000332	0.00121	CcSEcCtD
Dexmedetomidine—CYP2E1—brain—Alzheimer's disease	0.000332	0.00955	CbGeAlD
Dexmedetomidine—CYP2D6—central nervous system—Alzheimer's disease	0.000331	0.00952	CbGeAlD
Dexmedetomidine—Diarrhoea—Donepezil—Alzheimer's disease	0.000324	0.00118	CcSEcCtD
Dexmedetomidine—CYP2D6—cerebellum—Alzheimer's disease	0.000324	0.00931	CbGeAlD
Dexmedetomidine—Dizziness—Donepezil—Alzheimer's disease	0.000313	0.00114	CcSEcCtD
Dexmedetomidine—Vomiting—Donepezil—Alzheimer's disease	0.000301	0.0011	CcSEcCtD
Dexmedetomidine—Rash—Donepezil—Alzheimer's disease	0.000298	0.00109	CcSEcCtD
Dexmedetomidine—Dermatitis—Donepezil—Alzheimer's disease	0.000298	0.00109	CcSEcCtD
Dexmedetomidine—Headache—Donepezil—Alzheimer's disease	0.000296	0.00108	CcSEcCtD
Dexmedetomidine—Diarrhoea—Memantine—Alzheimer's disease	0.000294	0.00107	CcSEcCtD
Dexmedetomidine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000288	0.00105	CcSEcCtD
Dexmedetomidine—Dizziness—Memantine—Alzheimer's disease	0.000284	0.00104	CcSEcCtD
Dexmedetomidine—Nausea—Donepezil—Alzheimer's disease	0.000281	0.00103	CcSEcCtD
Dexmedetomidine—Dizziness—Rivastigmine—Alzheimer's disease	0.000278	0.00101	CcSEcCtD
Dexmedetomidine—Vomiting—Memantine—Alzheimer's disease	0.000273	0.000997	CcSEcCtD
Dexmedetomidine—Rash—Memantine—Alzheimer's disease	0.000271	0.000988	CcSEcCtD
Dexmedetomidine—Dermatitis—Memantine—Alzheimer's disease	0.000271	0.000987	CcSEcCtD
Dexmedetomidine—Headache—Memantine—Alzheimer's disease	0.000269	0.000982	CcSEcCtD
Dexmedetomidine—Vomiting—Rivastigmine—Alzheimer's disease	0.000267	0.000975	CcSEcCtD
Dexmedetomidine—Rash—Rivastigmine—Alzheimer's disease	0.000265	0.000967	CcSEcCtD
Dexmedetomidine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000265	0.000966	CcSEcCtD
Dexmedetomidine—Headache—Rivastigmine—Alzheimer's disease	0.000263	0.000961	CcSEcCtD
Dexmedetomidine—CYP2D6—brain—Alzheimer's disease	0.000263	0.00756	CbGeAlD
Dexmedetomidine—Nausea—Memantine—Alzheimer's disease	0.000255	0.000931	CcSEcCtD
Dexmedetomidine—Nausea—Rivastigmine—Alzheimer's disease	0.00025	0.000911	CcSEcCtD
Dexmedetomidine—ADRA2C—Signaling Pathways—IGF2—Alzheimer's disease	1.3e-05	0.000152	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—MTHFR—Alzheimer's disease	1.29e-05	0.000151	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	1.29e-05	0.000151	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—LPL—Alzheimer's disease	1.29e-05	0.00015	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR2A—Alzheimer's disease	1.28e-05	0.00015	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	1.28e-05	0.00015	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	1.28e-05	0.00015	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	1.28e-05	0.000149	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IGF2—Alzheimer's disease	1.28e-05	0.000149	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MEF2C—Alzheimer's disease	1.27e-05	0.000149	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	1.27e-05	0.000149	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IGF1R—Alzheimer's disease	1.25e-05	0.000147	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PRKCG—Alzheimer's disease	1.25e-05	0.000146	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IGF1R—Alzheimer's disease	1.23e-05	0.000144	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	1.23e-05	0.000144	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NGF—Alzheimer's disease	1.22e-05	0.000143	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	1.22e-05	0.000142	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.21e-05	0.000142	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—TP53—Alzheimer's disease	1.21e-05	0.000142	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—CALM1—Alzheimer's disease	1.21e-05	0.000141	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—APOE—Alzheimer's disease	1.2e-05	0.000141	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	1.2e-05	0.000141	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—LPL—Alzheimer's disease	1.2e-05	0.000141	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.2e-05	0.000141	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CALM1—Alzheimer's disease	1.2e-05	0.00014	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	1.2e-05	0.00014	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	1.19e-05	0.00014	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—LEP—Alzheimer's disease	1.19e-05	0.00014	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—APOE—Alzheimer's disease	1.19e-05	0.00014	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—CAV1—Alzheimer's disease	1.19e-05	0.00014	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MEF2C—Alzheimer's disease	1.19e-05	0.000139	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	1.19e-05	0.000139	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCR5—Alzheimer's disease	1.18e-05	0.000139	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—A2M—Alzheimer's disease	1.18e-05	0.000139	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CAV1—Alzheimer's disease	1.18e-05	0.000138	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	1.18e-05	0.000138	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	1.18e-05	0.000138	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	1.17e-05	0.000137	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	1.17e-05	0.000137	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	1.17e-05	0.000137	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PRKCG—Alzheimer's disease	1.17e-05	0.000137	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—LPL—Alzheimer's disease	1.17e-05	0.000137	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	1.16e-05	0.000136	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR2A—Alzheimer's disease	1.16e-05	0.000136	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	1.15e-05	0.000135	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—ESR1—Alzheimer's disease	1.14e-05	0.000133	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	1.14e-05	0.000133	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	1.14e-05	0.000133	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NGF—Alzheimer's disease	1.14e-05	0.000133	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—F2—Alzheimer's disease	1.13e-05	0.000132	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	1.12e-05	0.000131	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	1.11e-05	0.00013	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCR5—Alzheimer's disease	1.11e-05	0.00013	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	1.11e-05	0.000129	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	1.1e-05	0.000129	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NOTCH1—Alzheimer's disease	1.1e-05	0.000129	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—AKT1—Alzheimer's disease	1.09e-05	0.000128	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	1.09e-05	0.000127	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR2A—Alzheimer's disease	1.08e-05	0.000127	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CALM1—Alzheimer's disease	1.08e-05	0.000127	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—APOE—Alzheimer's disease	1.08e-05	0.000126	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—LEP—Alzheimer's disease	1.08e-05	0.000126	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—LPL—Alzheimer's disease	1.07e-05	0.000125	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CAV1—Alzheimer's disease	1.07e-05	0.000125	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	1.07e-05	0.000125	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	1.06e-05	0.000124	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.06e-05	0.000124	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	1.05e-05	0.000123	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	1.05e-05	0.000123	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PPARG—Alzheimer's disease	1.05e-05	0.000123	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—GSK3B—Alzheimer's disease	1.03e-05	0.000121	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	1.03e-05	0.000121	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—ESR1—Alzheimer's disease	1.03e-05	0.00012	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—INS—Alzheimer's disease	1.03e-05	0.00012	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CREB1—Alzheimer's disease	1.03e-05	0.00012	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—AKT1—Alzheimer's disease	1.02e-05	0.00012	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—INS—Alzheimer's disease	1.02e-05	0.000119	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	1.02e-05	0.000119	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	1.02e-05	0.000119	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—F2—Alzheimer's disease	1.02e-05	0.000119	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CALM1—Alzheimer's disease	1.01e-05	0.000118	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—LPL—Alzheimer's disease	1.01e-05	0.000118	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—LEP—Alzheimer's disease	1.01e-05	0.000118	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—APOE—Alzheimer's disease	1.01e-05	0.000118	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCL2—Alzheimer's disease	1e-05	0.000117	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	9.99e-06	0.000117	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CAV1—Alzheimer's disease	9.97e-06	0.000117	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	9.95e-06	0.000116	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	9.94e-06	0.000116	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	9.91e-06	0.000116	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	9.91e-06	0.000116	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IGF1—Alzheimer's disease	9.86e-06	0.000115	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—TP53—Alzheimer's disease	9.84e-06	0.000115	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	9.82e-06	0.000115	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CALM1—Alzheimer's disease	9.81e-06	0.000115	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—APOE—Alzheimer's disease	9.78e-06	0.000114	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	9.75e-06	0.000114	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CAV1—Alzheimer's disease	9.69e-06	0.000113	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	9.69e-06	0.000113	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	9.67e-06	0.000113	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	9.65e-06	0.000113	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	9.65e-06	0.000113	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	9.65e-06	0.000113	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—ESR1—Alzheimer's disease	9.61e-06	0.000113	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—F2—Alzheimer's disease	9.49e-06	0.000111	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	9.48e-06	0.000111	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	9.47e-06	0.000111	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	9.46e-06	0.000111	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	9.34e-06	0.000109	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	9.33e-06	0.000109	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	9.29e-06	0.000109	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	9.26e-06	0.000108	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	9.24e-06	0.000108	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	9.21e-06	0.000108	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	9.14e-06	0.000107	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	9.09e-06	0.000106	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	9.06e-06	0.000106	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—NOS3—Alzheimer's disease	9.02e-06	0.000106	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CALM1—Alzheimer's disease	9.01e-06	0.000105	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	8.99e-06	0.000105	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—APOE—Alzheimer's disease	8.98e-06	0.000105	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	8.97e-06	0.000105	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	8.94e-06	0.000105	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	8.91e-06	0.000104	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CAV1—Alzheimer's disease	8.9e-06	0.000104	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	8.8e-06	0.000103	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	8.72e-06	0.000102	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	8.65e-06	0.000101	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	8.6e-06	0.000101	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	8.58e-06	0.0001	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	8.52e-06	9.97e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	8.51e-06	9.96e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CALM1—Alzheimer's disease	8.5e-06	9.94e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	8.47e-06	9.91e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—APOE—Alzheimer's disease	8.47e-06	9.91e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	8.46e-06	9.91e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	8.46e-06	9.9e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CAV1—Alzheimer's disease	8.39e-06	9.82e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—INS—Alzheimer's disease	8.35e-06	9.78e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	8.35e-06	9.77e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	8.33e-06	9.75e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	8.32e-06	9.74e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	8.31e-06	9.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	8.31e-06	9.72e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.31e-06	9.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	8.25e-06	9.66e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	8.21e-06	9.61e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	8.21e-06	9.61e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	8.19e-06	9.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	8.18e-06	9.57e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	8.18e-06	9.57e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	8.1e-06	9.48e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	8.07e-06	9.45e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	7.82e-06	9.16e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	7.81e-06	9.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	7.71e-06	9.03e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—INS—Alzheimer's disease	7.67e-06	8.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	7.66e-06	8.97e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—LPL—Alzheimer's disease	7.6e-06	8.9e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	7.59e-06	8.89e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	7.55e-06	8.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	7.54e-06	8.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	7.54e-06	8.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	7.42e-06	8.69e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PPARG—Alzheimer's disease	7.37e-06	8.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	7.33e-06	8.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—INS—Alzheimer's disease	7.23e-06	8.47e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	7.08e-06	8.29e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	7.07e-06	8.28e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	7.04e-06	8.24e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	7.02e-06	8.22e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	6.99e-06	8.18e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	6.98e-06	8.17e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	6.96e-06	8.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	6.92e-06	8.1e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	6.87e-06	8.05e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	6.85e-06	8.02e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	6.84e-06	8.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	6.81e-06	7.97e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	6.76e-06	7.91e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	6.73e-06	7.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	6.7e-06	7.84e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	6.46e-06	7.56e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	6.44e-06	7.54e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—LPL—Alzheimer's disease	6.44e-06	7.54e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	6.4e-06	7.49e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	6.39e-06	7.49e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOE—Alzheimer's disease	6.37e-06	7.46e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	6.36e-06	7.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	6.36e-06	7.45e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—NOS3—Alzheimer's disease	6.34e-06	7.42e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	6.31e-06	7.39e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	6.3e-06	7.38e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	6.3e-06	7.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	6.28e-06	7.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	6.26e-06	7.33e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	6.15e-06	7.2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	6.13e-06	7.17e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	5.91e-06	6.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	5.88e-06	6.89e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	5.87e-06	6.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	5.82e-06	6.81e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	5.8e-06	6.79e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	5.8e-06	6.79e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	5.79e-06	6.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	5.78e-06	6.76e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	5.55e-06	6.5e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—INS—Alzheimer's disease	5.44e-06	6.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	5.43e-06	6.36e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	5.42e-06	6.34e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOE—Alzheimer's disease	5.4e-06	6.32e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	5.35e-06	6.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	5.35e-06	6.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	5.34e-06	6.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.25e-06	6.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	5.2e-06	6.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	5.17e-06	6.05e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	4.99e-06	5.84e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	4.91e-06	5.75e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	4.87e-06	5.7e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	4.78e-06	5.6e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	4.77e-06	5.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	4.77e-06	5.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	4.7e-06	5.5e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—INS—Alzheimer's disease	4.61e-06	5.4e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	4.46e-06	5.22e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	4.41e-06	5.17e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	4.4e-06	5.14e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	4.37e-06	5.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—AKT1—Alzheimer's disease	4.15e-06	4.85e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	4.11e-06	4.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	4.11e-06	4.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	4.05e-06	4.74e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	4.04e-06	4.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	4.04e-06	4.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	4.02e-06	4.71e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	3.76e-06	4.4e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	3.71e-06	4.34e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	3.7e-06	4.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	3.7e-06	4.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	3.47e-06	4.06e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	3.41e-06	3.99e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	3.37e-06	3.94e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	3.33e-06	3.9e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	3.09e-06	3.62e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	3.05e-06	3.57e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—AKT1—Alzheimer's disease	2.92e-06	3.41e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	2.82e-06	3.3e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	2.19e-06	2.57e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.86e-06	2.18e-05	CbGpPWpGaD
